Precision Medicine Software Market, by Access Systems (Electronic Health Records, Data Warehouses, Registries, Other Systems); by Deployment (Cloud Based, On-Premise); By End User (Healthcare Providers, Research & Academic Institutes, Government Institutes, Pharmaceutical and Biotechnology Companies, Others); By Region (United States, Canada, Mexico, Rest of North America, France, The UK, Spain, Germany, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019–2027

Report ID :AMI-349 | Category : Healthcare It | Published Date : January, 2020 | Pages : 402 | Format :PDF

Industry Trends

Precision medicine is an approach to patient care that enables doctors to predict more accurately about which treatment and preventive measures for any particular disease will work as it considers individual variability in genes, lifestyle, and environment for each person when devising treatment procedures for patients. Precision medicine software assists healthcare providers or clinicians to deliver therapeutic value faster, manage healthcare costs, and improve patient’s safety and satisfaction or select right medicine for the right patient at the right time. To achieve this, clinicians are given tools in the form of tests and information-technology (IT) support, which are compatible with their clinical workflow and economically feasible to deploy in the modern health-care environment. These tools can simplify the process of managing the biological complexity that underlies human diseases. The precision medicine software market is gaining traction worldwide due to the growth of personal healthcare devices and integration of smart technologies in the healthcare system. The demand for precision medicine is rising across the world as various diseases such as cancer, heart conditions, and diabetes can be passed down genetically from parents to their children. Though precision medicine is not widely available, the growth in integration of big data healthcare organizations with pharmaceutical and biotechnology companies will bring the healthcare sector closer to the availability of precision medicine. Precision medicine carries high potential in emerging economies where there is a growing demand and awareness about advanced healthcare facilities among individuals or patients. However, concern regarding privacy of patient’s confidential information and high diagnosis costs associated with precision medicine are anticipated to create barriers to growth of the precision medicine software market during the forecast period.

The global precision medicine software market by access systems is bifurcated into: electronic health records (EHR), data warehouses, registries, and other systems, Technology that gathers patient’s health records (EHR) can be a prominent initiative for precision medicine. EHR are designed with the concept of one size fits all and are built to standardize processes. Adoption of EHR across several clinics and EHR linked bio-banks are providing opportunities for the translational and data driven research. Moreover, advanced digitization of health information and ongoing genomic research also propel its growth.

Precision medicine software market by deployment is bifurcated into cloud based and on-premise. Cloud based deployments are on high demand worldwide, and it is best suited for the enterprises who want to secure their sensitive data. Cloud based infrastructure could be accessed anywhere over the network and different variants such as public cloud, private cloud, hybrid cloud, and multi cloud. Artificial intelligence (AI) has the ability to reveal hidden patterns and potentially predict novel connections in biomedical data which human or traditional computing methods cannot achieve. IBM solutions are helping organizations to enable the discovery of new opportunities previously unseen in disconnected data and turning them into meaningful insights.

The global precision medicine software market by end user is bifurcated into healthcare providers, government institutes, research and academic institutes, pharmaceutical and biotechnology organizations, and others. Growing availability of precision medicine software and rising demand for personalized healthcare have supported the healthcare providers segment to account for the largest market share in 2018.

The global precision medicine software market revenue was valued at US$ 970.66 Mn in 2018 and is expected to grow at a CAGR of 12.3% during the forecast period from 2019 to 2027.

Global Precision Medicine Software Market Revenue (US$ Million), 2015 – 2027

Competitive Landscape

The report provides both, qualitative and quantitative research of global precision medicine software market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global precision medicine software market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarters, competitors, product/service type, application and specification, pricing, and gross margin.

The primary market participants in the global precision medicine software market include 2bPrecise, Syapse, Inc., IBM Corporation, Koninklijke Philips N.V., Oracle, Cloudera, Inc., Fabric Genomics, Gene42 Inc., LifeOmic Health, LLC, NantHealth, Inc., N-of-One, Inc. (A QIAGEN Company), PierianDx, SOPHiA GENETICS, Translational Software and TupeloLife, amongst others.

Global Precision Medicine Software Market

  • By Access Systems
    • Electronic Health Records
    • Data Warehouses
    • Registries
    • Other Systems
  • By Deployment
    • Cloud Based
    • On-Premise
  • By End User 
    • Healthcare Providers
    • Research & Academic Institutes
    • Government Institutes
    • Pharmaceutical and Biotechnology Companies
    • Others (Testing Labs, etc.)
  • By Region
    • North America
      • United States
      • Canada
      • Mexico
      • Rest of North America
    • Europe
      • France
      • The UK
      • Spain
      • Germany
      • Italy
      • Nordic Countries
        • Denmark
        • Finland
        • Iceland
        • Sweden
        • Norway
      • Benelux Union
        • Belgium
        • The Netherlands
        • Luxembourg
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • New Zealand
      • Australia
      • South Korea
      • Southeast Asia
        • Indonesia
        • Thailand
        • Malaysia
        • Singapore
        • Rest of Southeast Asia
      • Rest of Asia Pacific
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • Egypt
      • Kuwait
      • South Africa
      • Rest of Middle East & Africa
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America

 

Table of Contents

 


1.    Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2013 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2.    Key Target Audiences

3.    Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Precision Medicine Software Market

6.    Market Synopsis:  Precision Medicine Software Market

7.    Precision Medicine Software Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Precision Medicine Software Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Precision Medicine Software Market

7.6. Porter’s Five Force Analysis

7.7. PESTEL Analysis

8.    Global Precision Medicine Software Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global Precision Medicine Software Market Revenue (US$ Mn)

8.2. Global Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

8.2.1. Electronic Health Records

8.2.1.1. Definition

8.2.1.2. Market Estimation and Penetration, 2013 – 2018

8.2.1.3. Market Forecast, 2019 – 2027

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1.    North America

8.2.1.5.1.1. Market Estimation, 2013 – 2018

8.2.1.5.1.2. Market Forecast, 2019 – 2027

8.2.1.5.2.    Europe

8.2.1.5.2.1. Market Estimation, 2013 – 2018

8.2.1.5.2.2. Market Forecast, 2019 – 2027

8.2.1.5.3.    Asia Pacific

8.2.1.5.3.1. Market Estimation, 2013 – 2018

8.2.1.5.3.2. Market Forecast, 2019 – 2027

8.2.1.5.4.    Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2013 – 2018

8.2.1.5.4.2. Market Forecast, 2019 – 2027

8.2.1.5.5.    Latin America

8.2.1.5.5.1. Market Estimation, 2013 – 2018

8.2.1.5.5.2. Market Forecast, 2019 – 2027

8.2.2. Data Warehouses

8.2.2.1. Definition

8.2.2.2. Market Estimation and Penetration, 2013 – 2018

8.2.2.3. Market Forecast, 2019 – 2027

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1.    North America

8.2.2.5.1.1. Market Estimation, 2013 – 2018

8.2.2.5.1.2. Market Forecast, 2019 – 2027

8.2.2.5.2.    Europe

8.2.2.5.2.1. Market Estimation, 2013 – 2018

8.2.2.5.2.2. Market Forecast, 2019 – 2027

8.2.2.5.3.    Asia Pacific

8.2.2.5.3.1. Market Estimation, 2013 – 2018

8.2.2.5.3.2. Market Forecast, 2019 – 2027

8.2.2.5.4.    Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2013 – 2018

8.2.2.5.4.2. Market Forecast, 2019 – 2027

8.2.2.5.5.    Latin America

8.2.2.5.5.1. Market Estimation, 2013 – 2018

8.2.2.5.5.2. Market Forecast, 2019 – 2027

8.2.3. Registries

8.2.3.1. Definition

8.2.3.2. Market Estimation and Penetration, 2013 – 2018

8.2.3.3. Market Forecast, 2019 – 2027

8.2.3.4. Compound Annual Growth Rate (CAGR)

8.2.3.5. Regional Bifurcation

8.2.3.5.1.    North America

8.2.3.5.1.1. Market Estimation, 2013 – 2018

8.2.3.5.1.2. Market Forecast, 2019 – 2027

8.2.3.5.2.    Europe

8.2.3.5.2.1. Market Estimation, 2013 – 2018

8.2.3.5.2.2. Market Forecast, 2019 – 2027

8.2.3.5.3.    Asia Pacific

8.2.3.5.3.1. Market Estimation, 2013 – 2018

8.2.3.5.3.2. Market Forecast, 2019 – 2027

8.2.3.5.4.    Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2013 – 2018

8.2.3.5.4.2. Market Forecast, 2019 – 2027

8.2.3.5.5.    Latin America

8.2.3.5.5.1. Market Estimation, 2013 – 2018

8.2.3.5.5.2. Market Forecast, 2019 – 2027

8.2.4. Other Systems

8.2.4.1. Definition

8.2.4.2. Market Estimation and Penetration, 2013 – 2018

8.2.4.3. Market Forecast, 2019 – 2027

8.2.4.4. Compound Annual Growth Rate (CAGR)

8.2.4.5. Regional Bifurcation

8.2.4.5.1.    North America

8.2.4.5.1.1. Market Estimation, 2013 – 2018

8.2.4.5.1.2. Market Forecast, 2019 – 2027

8.2.4.5.2.    Europe

8.2.4.5.2.1. Market Estimation, 2013 – 2018

8.2.4.5.2.2. Market Forecast, 2019 – 2027

8.2.4.5.3.    Asia Pacific

8.2.4.5.3.1. Market Estimation, 2013 – 2018

8.2.4.5.3.2. Market Forecast, 2019 – 2027

8.2.4.5.4.    Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2013 – 2018

8.2.4.5.4.2. Market Forecast, 2019 – 2027

8.2.4.5.5.    Latin America

8.2.4.5.5.1. Market Estimation, 2013 – 2018

8.2.4.5.5.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Access Systems

9.    Global Precision Medicine Software Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

9.2.1. Cloud Based

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2013 – 2018

9.2.1.3. Market Forecast, 2019 – 2027

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1.    North America

9.2.1.5.1.1. Market Estimation, 2013 – 2018

9.2.1.5.1.2. Market Forecast, 2019 – 2027

9.2.1.5.2.    Europe

9.2.1.5.2.1. Market Estimation, 2013 – 2018

9.2.1.5.2.2. Market Forecast, 2019 – 2027

9.2.1.5.3.    Asia Pacific

9.2.1.5.3.1. Market Estimation, 2013 – 2018

9.2.1.5.3.2. Market Forecast, 2019 – 2027

9.2.1.5.4.    Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2013 – 2018

9.2.1.5.4.2. Market Forecast, 2019 – 2027

9.2.1.5.5.    Latin America

9.2.1.5.5.1. Market Estimation, 2013 – 2018

9.2.1.5.5.2. Market Forecast, 2019 – 2027

9.2.2. On-Premise

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2013 – 2018

9.2.2.3. Market Forecast, 2019 – 2027

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1.    North America

9.2.2.5.1.1. Market Estimation, 2013 – 2018

9.2.2.5.1.2. Market Forecast, 2019 – 2027

9.2.2.5.2.    Europe

9.2.2.5.2.1. Market Estimation, 2013 – 2018

9.2.2.5.2.2. Market Forecast, 2019 – 2027

9.2.2.5.3.    Asia Pacific

9.2.2.5.3.1. Market Estimation, 2013 – 2018

9.2.2.5.3.2. Market Forecast, 2019 – 2027

9.2.2.5.4.    Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2013 – 2018

9.2.2.5.4.2. Market Forecast, 2019 – 2027

9.2.2.5.5.    Latin America

9.2.2.5.5.1. Market Estimation, 2013 – 2018

9.2.2.5.5.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Deployment

10. Global Precision Medicine Software Market Analysis and Forecasts, 2019 – 2027

10.1. Overview

10.2. Global Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

10.2.1. Healthcare Providers

10.2.1.1. Definition

10.2.1.2. Market Estimation and Penetration, 2013 – 2018

10.2.1.3. Market Forecast, 2019 – 2027

10.2.1.4. Compound Annual Growth Rate (CAGR)

10.2.1.5. Regional Bifurcation

10.2.1.5.1.  North America

10.2.1.5.1.1. Market Estimation, 2013 – 2018

10.2.1.5.1.2. Market Forecast, 2019 – 2027

10.2.1.5.2.  Europe

10.2.1.5.2.1. Market Estimation, 2013 – 2018

10.2.1.5.2.2. Market Forecast, 2019 – 2027

10.2.1.5.3.  Asia Pacific

10.2.1.5.3.1. Market Estimation, 2013 – 2018

10.2.1.5.3.2. Market Forecast, 2019 – 2027

10.2.1.5.4.  Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2013 – 2018

10.2.1.5.4.2. Market Forecast, 2019 – 2027

10.2.1.5.5.  Latin America

10.2.1.5.5.1. Market Estimation, 2013 – 2018

10.2.1.5.5.2. Market Forecast, 2019 – 2027

10.2.2. Research and Academic Institutes

10.2.2.1. Definition

10.2.2.2. Market Estimation and Penetration, 2013 – 2018

10.2.2.3. Market Forecast, 2019 – 2027

10.2.2.4. Compound Annual Growth Rate (CAGR)

10.2.2.5. Regional Bifurcation

10.2.2.5.1.  North America

10.2.2.5.1.1. Market Estimation, 2013 – 2018

10.2.2.5.1.2. Market Forecast, 2019 – 2027

10.2.2.5.2.  Europe

10.2.2.5.2.1. Market Estimation, 2013 – 2018

10.2.2.5.2.2. Market Forecast, 2019 – 2027

10.2.2.5.3.  Asia Pacific

10.2.2.5.3.1. Market Estimation, 2013 – 2018

10.2.2.5.3.2. Market Forecast, 2019 – 2027

10.2.2.5.4.  Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2013 – 2018

10.2.2.5.4.2. Market Forecast, 2019 – 2027

10.2.2.5.5.  Latin America

10.2.2.5.5.1. Market Estimation, 2013 – 2018

10.2.2.5.5.2. Market Forecast, 2019 – 2027

10.2.3. Government Institutes

10.2.3.1. Definition

10.2.3.2. Market Estimation and Penetration, 2013 – 2018

10.2.3.3. Market Forecast, 2019 – 2027

10.2.3.4. Compound Annual Growth Rate (CAGR)

10.2.3.5. Regional Bifurcation

10.2.3.5.1.  North America

10.2.3.5.1.1. Market Estimation, 2013 – 2018

10.2.3.5.1.2. Market Forecast, 2019 – 2027

10.2.3.5.2.  Europe

10.2.3.5.2.1. Market Estimation, 2013 – 2018

10.2.3.5.2.2. Market Forecast, 2019 – 2027

10.2.3.5.3.  Asia Pacific

10.2.3.5.3.1. Market Estimation, 2013 – 2018

10.2.3.5.3.2. Market Forecast, 2019 – 2027

10.2.3.5.4.  Middle East and Africa

10.2.3.5.4.1. Market Estimation, 2013 – 2018

10.2.3.5.4.2. Market Forecast, 2019 – 2027

10.2.3.5.5.  Latin America

10.2.3.5.5.1. Market Estimation, 2013 – 2018

10.2.3.5.5.2. Market Forecast, 2019 – 2027

10.2.4. Pharmaceutical and Biotechnology Companies

10.2.4.1. Definition

10.2.4.2. Market Estimation and Penetration, 2013 – 2018

10.2.4.3. Market Forecast, 2019 – 2027

10.2.4.4. Compound Annual Growth Rate (CAGR)

10.2.4.5. Regional Bifurcation

10.2.4.5.1.  North America

10.2.4.5.1.1. Market Estimation, 2013 – 2018

10.2.4.5.1.2. Market Forecast, 2019 – 2027

10.2.4.5.2.  Europe

10.2.4.5.2.1. Market Estimation, 2013 – 2018

10.2.4.5.2.2. Market Forecast, 2019 – 2027

10.2.4.5.3.  Asia Pacific

10.2.4.5.3.1. Market Estimation, 2013 – 2018

10.2.4.5.3.2. Market Forecast, 2019 – 2027

10.2.4.5.4.  Middle East and Africa

10.2.4.5.4.1. Market Estimation, 2013 – 2018

10.2.4.5.4.2. Market Forecast, 2019 – 2027

10.2.4.5.5.  Latin America

10.2.4.5.5.1. Market Estimation, 2013 – 2018

10.2.4.5.5.2. Market Forecast, 2019 – 2027

10.2.5. Others (Testing Labs, etc.)

10.2.5.1. Definition

10.2.5.2. Market Estimation and Penetration, 2013 – 2018

10.2.5.3. Market Forecast, 2019 – 2027

10.2.5.4. Compound Annual Growth Rate (CAGR)

10.2.5.5. Regional Bifurcation

10.2.5.5.1.  North America

10.2.5.5.1.1. Market Estimation, 2013 – 2018

10.2.5.5.1.2. Market Forecast, 2019 – 2027

10.2.5.5.2.  Europe

10.2.5.5.2.1. Market Estimation, 2013 – 2018

10.2.5.5.2.2. Market Forecast, 2019 – 2027

10.2.5.5.3.  Asia Pacific

10.2.5.5.3.1. Market Estimation, 2013 – 2018

10.2.5.5.3.2. Market Forecast, 2019 – 2027

10.2.5.5.4.  Middle East and Africa

10.2.5.5.4.1. Market Estimation, 2013 – 2018

10.2.5.5.4.2. Market Forecast, 2019 – 2027

10.2.5.5.5.  Latin America

10.2.5.5.5.1. Market Estimation, 2013 – 2018

10.2.5.5.5.2. Market Forecast, 2019 – 2027

10.3. Key Segment for Channeling Investments

10.3.1. By End User

11. North America Precision Medicine Software Market Analysis and Forecasts, 2019 - 2027

11.1. Overview

11.1.1. North America Precision Medicine Software Market Revenue (US$ Mn)

11.2. North America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

11.2.1. Electronic Health Records

11.2.2. Data Warehouses

11.2.3. Registries

11.2.4. Other Systems

11.3. North America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

11.3.1. Cloud Based

11.3.2. On-Premise

11.4. North America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

11.4.1. Healthcare Providers

11.4.2. Research and Academic Institutes

11.4.3. Government Institutes

11.4.4. Pharmaceutical and Biotechnology Companies

11.4.5. Others (Testing Labs, etc.)

11.5. North America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Country

11.5.1. U.S

11.5.1.1. U.S Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

11.5.1.1.1.  Electronic Health Records

11.5.1.1.2.  Data Warehouses

11.5.1.1.3.  Registries

11.5.1.1.4.  Other Systems

11.5.1.2. U.S Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

11.5.1.2.1.  Cloud Based

11.5.1.2.2.  On-Premise

11.5.1.3. U.S Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

11.5.1.3.1.  Healthcare Providers

11.5.1.3.2.  Research and Academic Institutes

11.5.1.3.3.  Government Institutes

11.5.1.3.4.  Pharmaceutical and Biotechnology Companies

11.5.1.3.5.  Others (Testing Labs, etc.)

11.5.2. Canada

11.5.2.1. Canada Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

11.5.2.1.1.  Electronic Health Records

11.5.2.1.2.  Data Warehouses

11.5.2.1.3.  Registries

11.5.2.1.4.  Other Systems

11.5.2.2. Canada Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

11.5.2.2.1.  Cloud Based

11.5.2.2.2.  On-Premise

11.5.2.3. Canada Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

11.5.2.3.1.  Healthcare Providers

11.5.2.3.2.  Research and Academic Institutes

11.5.2.3.3.  Government Institutes

11.5.2.3.4.  Pharmaceutical and Biotechnology Companies

11.5.2.3.5.  Others (Testing Labs, etc.)

11.5.3. Mexico

11.5.3.1. Mexico Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

11.5.3.1.1.  Electronic Health Records

11.5.3.1.2.  Data Warehouses

11.5.3.1.3.  Registries

11.5.3.1.4.  Other Systems

11.5.3.2. Mexico Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

11.5.3.2.1.  Cloud Based

11.5.3.2.2.  On-Premise

11.5.3.3. Mexico Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

11.5.3.3.1.  Healthcare Providers

11.5.3.3.2.  Research and Academic Institutes

11.5.3.3.3.  Government Institutes

11.5.3.3.4.  Pharmaceutical and Biotechnology Companies

11.5.3.3.5.  Others (Testing Labs, etc.)

11.5.4. Rest of North America

11.5.4.1. Rest of North America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

11.5.4.1.1.  Electronic Health Records

11.5.4.1.2.  Data Warehouses

11.5.4.1.3.  Registries

11.5.4.1.4.  Other Systems

11.5.4.2. Rest of North America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

11.5.4.2.1.  Cloud Based

11.5.4.2.2.  On-Premise

11.5.4.3. Rest of North America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

11.5.4.3.1.  Healthcare Providers

11.5.4.3.2.  Research and Academic Institutes

11.5.4.3.3.  Government Institutes

11.5.4.3.4.  Pharmaceutical and Biotechnology Companies

11.5.4.3.5.  Others (Testing Labs, etc.)

11.6. Key Segment for Channeling Investments

11.6.1. By Country

11.6.2. By Access Systems

11.6.3. By Deployment

11.6.4. By End User

12. Europe Precision Medicine Software Market Analysis and Forecasts, 2019 - 2027

12.1. Overview

12.1.1. Europe Precision Medicine Software Market Revenue (US$ Mn)

12.2. Europe Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

12.2.1. Electronic Health Records

12.2.2. Data Warehouses

12.2.3. Registries

12.2.4. Other Systems

12.3. Europe Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

12.3.1. Cloud Based

12.3.2. On-Premise

12.4. Europe Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

12.4.1. Healthcare Providers

12.4.2. Research and Academic Institutes

12.4.3. Government Institutes

12.4.4. Pharmaceutical and Biotechnology Companies

12.4.5. Others (Testing Labs, etc.)

12.5. Europe Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Country

12.5.1. France

12.5.1.1. France Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

12.5.1.1.1.  Electronic Health Records

12.5.1.1.2.  Data Warehouses

12.5.1.1.3.  Registries

12.5.1.1.4.  Other Systems

12.5.1.2. France Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

12.5.1.2.1.  Cloud Based

12.5.1.2.2.  On-Premise

12.5.1.3. France Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

12.5.1.3.1.  Healthcare Providers

12.5.1.3.2.  Research and Academic Institutes

12.5.1.3.3.  Government Institutes

12.5.1.3.4.  Pharmaceutical and Biotechnology Companies

12.5.1.3.5.  Others (Testing Labs, etc.)

12.5.2. The UK

12.5.2.1. The UK Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

12.5.2.1.1.  Electronic Health Records

12.5.2.1.2.  Data Warehouses

12.5.2.1.3.  Registries

12.5.2.1.4.  Other Systems

12.5.2.2. The UK Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

12.5.2.2.1.  Cloud Based

12.5.2.2.2.  On-Premise

12.5.2.3. The UK Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

12.5.2.3.1.  Healthcare Providers

12.5.2.3.2.  Research and Academic Institutes

12.5.2.3.3.  Government Institutes

12.5.2.3.4.  Pharmaceutical and Biotechnology Companies

12.5.2.3.5.  Others (Testing Labs, etc.)

12.5.3. Spain

12.5.3.1. Spain Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

12.5.3.1.1.  Electronic Health Records

12.5.3.1.2.  Data Warehouses

12.5.3.1.3.  Registries

12.5.3.1.4.  Other Systems

12.5.3.2. Spain Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

12.5.3.2.1.  Cloud Based

12.5.3.2.2.  On-Premise

12.5.3.3. Spain Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

12.5.3.3.1.  Healthcare Providers

12.5.3.3.2.  Research and Academic Institutes

12.5.3.3.3.  Government Institutes

12.5.3.3.4.  Pharmaceutical and Biotechnology Companies

12.5.3.3.5.  Others (Testing Labs, etc.)

12.5.4. Germany

12.5.4.1. Germany Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

12.5.4.1.1.  Electronic Health Records

12.5.4.1.2.  Data Warehouses

12.5.4.1.3.  Registries

12.5.4.1.4.  Other Systems

12.5.4.2. Germany Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

12.5.4.2.1.  Cloud Based

12.5.4.2.2.  On-Premise

12.5.4.3. Germany Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

12.5.4.3.1.  Healthcare Providers

12.5.4.3.2.  Research and Academic Institutes

12.5.4.3.3.  Government Institutes

12.5.4.3.4.  Pharmaceutical and Biotechnology Companies

12.5.4.3.5.  Others (Testing Labs, etc.)

12.5.5. Italy

12.5.5.1. Italy Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

12.5.5.1.1.  Electronic Health Records

12.5.5.1.2.  Data Warehouses

12.5.5.1.3.  Registries

12.5.5.1.4.  Other Systems

12.5.5.2. Italy Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

12.5.5.2.1.  Cloud Based

12.5.5.2.2.  On-Premise

12.5.5.3. Italy Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

12.5.5.3.1.  Healthcare Providers

12.5.5.3.2.  Research and Academic Institutes

12.5.5.3.3.  Government Institutes

12.5.5.3.4.  Pharmaceutical and Biotechnology Companies

12.5.5.3.5.  Others (Testing Labs, etc.)

12.5.6. Nordic Countries

12.5.6.1. Nordic Countries Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

12.5.6.1.1.  Electronic Health Records

12.5.6.1.2.  Data Warehouses

12.5.6.1.3.  Registries

12.5.6.1.4.  Other Systems

12.5.6.2. Nordic Countries Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

12.5.6.2.1.  Cloud Based

12.5.6.2.2.  On-Premise

12.5.6.3. Nordic Countries Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

12.5.6.3.1.  Healthcare Providers

12.5.6.3.2.  Research and Academic Institutes

12.5.6.3.3.  Government Institutes

12.5.6.3.4.  Pharmaceutical and Biotechnology Companies

12.5.6.3.5.  Others (Testing Labs, etc.)

12.5.6.4. Nordic Countries Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Country

12.5.6.4.1.  Denmark

12.5.6.4.2.  Finland

12.5.6.4.3.  Iceland

12.5.6.4.4.  Sweden

12.5.6.4.5.  Norway

12.5.7. Benelux Union

12.5.7.1. Benelux Union Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

12.5.7.1.1.  Electronic Health Records

12.5.7.1.2.  Data Warehouses

12.5.7.1.3.  Registries

12.5.7.1.4.  Other Systems

12.5.7.2. Benelux Union Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

12.5.7.2.1.  Cloud Based

12.5.7.2.2.  On-Premise

12.5.7.3. Benelux Union Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

12.5.7.3.1.  Healthcare Providers

12.5.7.3.2.  Research and Academic Institutes

12.5.7.3.3.  Government Institutes

12.5.7.3.4.  Pharmaceutical and Biotechnology Companies

12.5.7.3.5.  Others (Testing Labs, etc.)

12.5.7.4. Benelux Union Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Country

12.5.7.4.1.  Belgium

12.5.7.4.2.  The Netherlands

12.5.7.4.3.  Luxembourg

12.5.8. Rest of Europe

12.5.8.1. Rest of Europe Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

12.5.8.1.1.  Electronic Health Records

12.5.8.1.2.  Data Warehouses

12.5.8.1.3.  Registries

12.5.8.1.4.  Other Systems

12.5.8.2. Rest of Europe Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

12.5.8.2.1.  Cloud Based

12.5.8.2.2.  On-Premise

12.5.8.3. Rest of Europe Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

12.5.8.3.1.  Healthcare Providers

12.5.8.3.2.  Research and Academic Institutes

12.5.8.3.3.  Government Institutes

12.5.8.3.4.  Pharmaceutical and Biotechnology Companies

12.5.8.3.5.  Others (Testing Labs, etc.)

12.6. Key Segment for Channeling Investments

12.6.1. By Country

12.6.2. By Access Systems

12.6.3. By Deployment

12.6.4. By End User

13. Asia Pacific Precision Medicine Software Market Analysis and Forecasts, 2019 - 2027

13.1. Overview

13.1.1. Asia Pacific Precision Medicine Software Market Revenue (US$ Mn)

13.2. Asia Pacific Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

13.2.1. Electronic Health Records

13.2.2. Data Warehouses

13.2.3. Registries

13.2.4. Other Systems

13.3. Asia Pacific Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

13.3.1. Cloud Based

13.3.2. On-Premise

13.4. Asia Pacific Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

13.4.1. Healthcare Providers

13.4.2. Research and Academic Institutes

13.4.3. Government Institutes

13.4.4. Pharmaceutical and Biotechnology Companies

13.4.5. Others (Testing Labs, etc.)

13.5. Asia Pacific Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Country

13.5.1. China

13.5.1.1. China Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

13.5.1.1.1.  Electronic Health Records

13.5.1.1.2.  Data Warehouses

13.5.1.1.3.  Registries

13.5.1.1.4.  Other Systems

13.5.1.2. China Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

13.5.1.2.1.  Cloud Based

13.5.1.2.2.  On-Premise

13.5.1.3. China Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

13.5.1.3.1.  Healthcare Providers

13.5.1.3.2.  Research and Academic Institutes

13.5.1.3.3.  Government Institutes

13.5.1.3.4.  Pharmaceutical and Biotechnology Companies

13.5.1.3.5.  Others (Testing Labs, etc.)

13.5.2. Japan

13.5.2.1. Japan Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

13.5.2.1.1.  Electronic Health Records

13.5.2.1.2.  Data Warehouses

13.5.2.1.3.  Registries

13.5.2.1.4.  Other Systems

13.5.2.2. Japan Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

13.5.2.2.1.  Cloud Based

13.5.2.2.2.  On-Premise

13.5.2.3. Japan Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

13.5.2.3.1.  Healthcare Providers

13.5.2.3.2.  Research and Academic Institutes

13.5.2.3.3.  Government Institutes

13.5.2.3.4.  Pharmaceutical and Biotechnology Companies

13.5.2.3.5.  Others (Testing Labs, etc.)

13.5.3. India

13.5.3.1. India Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

13.5.3.1.1.  Electronic Health Records

13.5.3.1.2.  Data Warehouses

13.5.3.1.3.  Registries

13.5.3.1.4.  Other Systems

13.5.3.2. India Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

13.5.3.2.1.  Cloud Based

13.5.3.2.2.  On-Premise

13.5.3.3. India Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

13.5.3.3.1.  Healthcare Providers

13.5.3.3.2.  Research and Academic Institutes

13.5.3.3.3.  Government Institutes

13.5.3.3.4.  Pharmaceutical and Biotechnology Companies

13.5.3.3.5.  Others (Testing Labs, etc.)

13.5.4. New Zealand

13.5.4.1. New Zealand Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

13.5.4.1.1.  Electronic Health Records

13.5.4.1.2.  Data Warehouses

13.5.4.1.3.  Registries

13.5.4.1.4.  Other Systems

13.5.4.2. New Zealand Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

13.5.4.2.1.  Cloud Based

13.5.4.2.2.  On-Premise

13.5.4.3. New Zealand Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

13.5.4.3.1.  Healthcare Providers

13.5.4.3.2.  Research and Academic Institutes

13.5.4.3.3.  Government Institutes

13.5.4.3.4.  Pharmaceutical and Biotechnology Companies

13.5.4.3.5.  Others (Testing Labs, etc.)

13.5.5. Australia

13.5.5.1. Australia Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

13.5.5.1.1.  Electronic Health Records

13.5.5.1.2.  Data Warehouses

13.5.5.1.3.  Registries

13.5.5.1.4.  Other Systems

13.5.5.2. Australia Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

13.5.5.2.1.  Cloud Based

13.5.5.2.2.  On-Premise

13.5.5.3. Australia Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

13.5.5.3.1.  Healthcare Providers

13.5.5.3.2.  Research and Academic Institutes

13.5.5.3.3.  Government Institutes

13.5.5.3.4.  Pharmaceutical and Biotechnology Companies

13.5.5.3.5.  Others (Testing Labs, etc.)

13.5.6. South Korea

13.5.6.1. South Korea Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

13.5.6.1.1.  Electronic Health Records

13.5.6.1.2.  Data Warehouses

13.5.6.1.3.  Registries

13.5.6.1.4.  Other Systems

13.5.6.2. South Korea Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

13.5.6.2.1.  Cloud Based

13.5.6.2.2.  On-Premise

13.5.6.3. South Korea Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

13.5.6.3.1.  Healthcare Providers

13.5.6.3.2.  Research and Academic Institutes

13.5.6.3.3.  Government Institutes

13.5.6.3.4.  Pharmaceutical and Biotechnology Companies

13.5.6.3.5.  Others (Testing Labs, etc.)

13.5.7. Southeast Asia

13.5.7.1. Southeast Asia Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

13.5.7.1.1.  Electronic Health Records

13.5.7.1.2.  Data Warehouses

13.5.7.1.3.  Registries

13.5.7.1.4.  Other Systems

13.5.7.2. Southeast Asia Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

13.5.7.2.1.  Cloud Based

13.5.7.2.2.  On-Premise

13.5.7.3. Southeast Asia Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

13.5.7.3.1.  Healthcare Providers

13.5.7.3.2.  Research and Academic Institutes

13.5.7.3.3.  Government Institutes

13.5.7.3.4.  Pharmaceutical and Biotechnology Companies

13.5.7.3.5.  Others (Testing Labs, etc.)

13.5.7.4. Southeast Asia Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Country

13.5.7.4.1.  Indonesia

13.5.7.4.2.  Thailand

13.5.7.4.3.  Malaysia

13.5.7.4.4.  Singapore

13.5.7.4.5.  Rest of Southeast Asia

13.5.8. Rest of Asia Pacific

13.5.8.1. Rest of Asia Pacific Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

13.5.8.1.1.  Electronic Health Records

13.5.8.1.2.  Data Warehouses

13.5.8.1.3.  Registries

13.5.8.1.4.  Other Systems

13.5.8.2. Rest of Asia Pacific Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

13.5.8.2.1.  Cloud Based

13.5.8.2.2.  On-Premise

13.5.8.3. Rest of Asia Pacific Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

13.5.8.3.1.  Healthcare Providers

13.5.8.3.2.  Research and Academic Institutes

13.5.8.3.3.  Government Institutes

13.5.8.3.4.  Pharmaceutical and Biotechnology Companies

13.5.8.3.5.  Others (Testing Labs, etc.)

13.6. Key Segment for Channeling Investments

13.6.1. By Country

13.6.2. By Access Systems

13.6.3. By Deployment

13.6.4. By End User

14. Middle East and Africa Precision Medicine Software Market Analysis and Forecasts, 2019 - 2027

14.1. Overview

14.1.1. Middle East and Africa Precision Medicine Software Market Revenue (US$ Mn)

14.2. Middle East and Africa Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

14.2.1. Electronic Health Records

14.2.2. Data Warehouses

14.2.3. Registries

14.2.4. Other Systems

14.3. Middle East and Africa Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

14.3.1. Cloud Based

14.3.2. On-Premise

14.4. Middle East and Africa Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

14.4.1. Healthcare Providers

14.4.2. Research and Academic Institutes

14.4.3. Government Institutes

14.4.4. Pharmaceutical and Biotechnology Companies

14.4.5. Others (Testing Labs, etc.)

14.5. Middle East and Africa Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Country

14.5.1. Saudi Arabia

14.5.1.1. Saudi Arabia Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

14.5.1.1.1.  Electronic Health Records

14.5.1.1.2.  Data Warehouses

14.5.1.1.3.  Registries

14.5.1.1.4.  Other Systems

14.5.1.2. Saudi Arabia Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

14.5.1.2.1.  Cloud Based

14.5.1.2.2.  On-Premise

14.5.1.3. Saudi Arabia Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

14.5.1.3.1.  Healthcare Providers

14.5.1.3.2.  Research and Academic Institutes

14.5.1.3.3.  Government Institutes

14.5.1.3.4.  Pharmaceutical and Biotechnology Companies

14.5.1.3.5.  Others (Testing Labs, etc.)

14.5.2. UAE

14.5.2.1. UAE Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

14.5.2.1.1.  Electronic Health Records

14.5.2.1.2.  Data Warehouses

14.5.2.1.3.  Registries

14.5.2.1.4.  Other Systems

14.5.2.2. UAE Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

14.5.2.2.1.  Cloud Based

14.5.2.2.2.  On-Premise

14.5.2.3. UAE Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

14.5.2.3.1.  Healthcare Providers

14.5.2.3.2.  Research and Academic Institutes

14.5.2.3.3.  Government Institutes

14.5.2.3.4.  Pharmaceutical and Biotechnology Companies

14.5.2.3.5.  Others (Testing Labs, etc.)

14.5.3. Egypt

14.5.3.1. Egypt Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

14.5.3.1.1.  Electronic Health Records

14.5.3.1.2.  Data Warehouses

14.5.3.1.3.  Registries

14.5.3.1.4.  Other Systems

14.5.3.2. Egypt Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

14.5.3.2.1.  Cloud Based

14.5.3.2.2.  On-Premise

14.5.3.3. Egypt Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

14.5.3.3.1.  Healthcare Providers

14.5.3.3.2.  Research and Academic Institutes

14.5.3.3.3.  Government Institutes

14.5.3.3.4.  Pharmaceutical and Biotechnology Companies

14.5.3.3.5.  Others (Testing Labs, etc.)

14.5.4. Kuwait

14.5.4.1. Kuwait Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

14.5.4.1.1.  Electronic Health Records

14.5.4.1.2.  Data Warehouses

14.5.4.1.3.  Registries

14.5.4.1.4.  Other Systems

14.5.4.2. Kuwait Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

14.5.4.2.1.  Cloud Based

14.5.4.2.2.  On-Premise

14.5.4.3. Kuwait Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

14.5.4.3.1.  Healthcare Providers

14.5.4.3.2.  Research and Academic Institutes

14.5.4.3.3.  Government Institutes

14.5.4.3.4.  Pharmaceutical and Biotechnology Companies

14.5.4.3.5.  Others (Testing Labs, etc.)

14.5.5. South Africa

14.5.5.1. South Africa Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

14.5.5.1.1.  Electronic Health Records

14.5.5.1.2.  Data Warehouses

14.5.5.1.3.  Registries

14.5.5.1.4.  Other Systems

14.5.5.2. South Africa Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

14.5.5.2.1.  Cloud Based

14.5.5.2.2.  On-Premise

14.5.5.3. South Africa Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

14.5.5.3.1.  Healthcare Providers

14.5.5.3.2.  Research and Academic Institutes

14.5.5.3.3.  Government Institutes

14.5.5.3.4.  Pharmaceutical and Biotechnology Companies

14.5.5.3.5.  Others (Testing Labs, etc.)

14.5.6. Rest of Middle East & Africa

14.5.6.1. Rest of Middle East & Africa Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

14.5.6.1.1.  Electronic Health Records

14.5.6.1.2.  Data Warehouses

14.5.6.1.3.  Registries

14.5.6.1.4.  Other Systems

14.5.6.2. Rest of Middle East & Africa Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

14.5.6.2.1.  Cloud Based

14.5.6.2.2.  On-Premise

14.5.6.3. Rest of Middle East & Africa Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

14.5.6.3.1.  Healthcare Providers

14.5.6.3.2.  Research and Academic Institutes

14.5.6.3.3.  Government Institutes

14.5.6.3.4.  Pharmaceutical and Biotechnology Companies

14.5.6.3.5.  Others (Testing Labs, etc.)

14.6. Key Segment for Channeling Investments

14.6.1. By Country

14.6.2. By Access Systems

14.6.3. By Deployment

14.6.4. By End User

15. Latin America Precision Medicine Software Market Analysis and Forecasts, 2019 - 2027

15.1. Overview

15.1.1. Latin America Precision Medicine Software Market Revenue (US$ Mn)

15.2. Latin America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

15.2.1. Electronic Health Records

15.2.2. Data Warehouses

15.2.3. Registries

15.2.4. Other Systems

15.3. Latin America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

15.3.1. Cloud Based

15.3.2. On-Premise

15.4. Latin America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

15.4.1. Healthcare Providers

15.4.2. Research and Academic Institutes

15.4.3. Government Institutes

15.4.4. Pharmaceutical and Biotechnology Companies

15.4.5. Others (Testing Labs, etc.)

15.5. Latin America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Country

15.5.1. Brazil

15.5.1.1. Brazil Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

15.5.1.1.1.  Electronic Health Records

15.5.1.1.2.  Data Warehouses

15.5.1.1.3.  Registries

15.5.1.1.4.  Other Systems

15.5.1.2. Brazil Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

15.5.1.2.1.  Cloud Based

15.5.1.2.2.  On-Premise

15.5.1.3. Brazil Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

15.5.1.3.1.  Healthcare Providers

15.5.1.3.2.  Research and Academic Institutes

15.5.1.3.3.  Government Institutes

15.5.1.3.4.  Pharmaceutical and Biotechnology Companies

15.5.1.3.5.  Others (Testing Labs, etc.)

15.5.2. Argentina

15.5.2.1. Argentina Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

15.5.2.1.1.  Electronic Health Records

15.5.2.1.2.  Data Warehouses

15.5.2.1.3.  Registries

15.5.2.1.4.  Other Systems

15.5.2.2. Argentina Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

15.5.2.2.1.  Cloud Based

15.5.2.2.2.  On-Premise

15.5.2.3. Argentina Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

15.5.2.3.1.  Healthcare Providers

15.5.2.3.2.  Research and Academic Institutes

15.5.2.3.3.  Government Institutes

15.5.2.3.4.  Pharmaceutical and Biotechnology Companies

15.5.2.3.5.  Others (Testing Labs, etc.)

15.5.3. Rest of Latin America

15.5.3.1. Rest of Latin America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Access Systems

15.5.3.1.1.  Electronic Health Records

15.5.3.1.2.  Data Warehouses

15.5.3.1.3.  Registries

15.5.3.1.4.  Other Systems

15.5.3.2. Rest of Latin America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By Deployment

15.5.3.2.1.  Cloud Based

15.5.3.2.2.  On-Premise

15.5.3.3. Rest of Latin America Precision Medicine Software Market Revenue (US$ Mn) and Forecasts, By End User

15.5.3.3.1.  Healthcare Providers

15.5.3.3.2.  Research and Academic Institutes

15.5.3.3.3.  Government Institutes

15.5.3.3.4.  Pharmaceutical and Biotechnology Companies

15.5.3.3.5.  Others (Testing Labs, etc.)

15.6. Key Segment for Channeling Investments

15.6.1. By Country

15.6.2. By Access Systems

15.6.3. By Deployment

15.6.4. By End User

16. Competitive Benchmarking

16.1. Market Share Analysis, 2018

16.2. Global Presence and Growth Strategies

16.2.1. Mergers and Acquisitions

16.2.2. Product Launches

16.2.3. Investments Trends

16.2.4. R&D Initiatives

17. Player Profiles

17.1. 2bPrecise

17.1.1. Company Details

17.1.2. Company Overview

17.1.3. Product Offerings

17.1.4. Key Developments

17.1.5. Financial Analysis

17.1.6. SWOT Analysis

17.1.7. Business Strategies

17.2. Cloudera, Inc.

17.2.1. Company Details

17.2.2. Company Overview

17.2.3. Product Offerings

17.2.4. Key Developments

17.2.5. Financial Analysis

17.2.6. SWOT Analysis

17.2.7. Business Strategies

17.3. Fabric Genomics, Inc.

17.3.1. Company Details

17.3.2. Company Overview

17.3.3. Product Offerings

17.3.4. Key Developments

17.3.5. Financial Analysis

17.3.6. SWOT Analysis

17.3.7. Business Strategies

17.4. Gene42 Inc.

17.4.1. Company Details

17.4.2. Company Overview

17.4.3. Product Offerings

17.4.4. Key Developments

17.4.5. Financial Analysis

17.4.6. SWOT Analysis

17.4.7. Business Strategies

17.5. IBM Corporation

17.5.1. Company Details

17.5.2. Company Overview

17.5.3. Product Offerings

17.5.4. Key Developments

17.5.5. Financial Analysis

17.5.6. SWOT Analysis

17.5.7. Business Strategies

17.6. Koninklijke Philips N.V.

17.6.1. Company Details

17.6.2. Company Overview

17.6.3. Product Offerings

17.6.4. Key Developments

17.6.5. Financial Analysis

17.6.6. SWOT Analysis

17.6.7. Business Strategies

17.7. LifeOmic Health, LLC

17.7.1. Company Details

17.7.2. Company Overview

17.7.3. Product Offerings

17.7.4. Key Developments

17.7.5. Financial Analysis

17.7.6. SWOT Analysis

17.7.7. Business Strategies

 

17.8. NantHealth, Inc.

17.8.1. Company Details

17.8.2. Company Overview

17.8.3. Product Offerings

17.8.4. Key Developments

17.8.5. Financial Analysis

17.8.6. SWOT Analysis

17.8.7. Business Strategies

17.9. N-of-One, Inc. (QIAGEN)

17.9.1. Company Details

17.9.2. Company Overview

17.9.3. Product Offerings

17.9.4. Key Developments

17.9.5. Financial Analysis

17.9.6. SWOT Analysis

17.9.7. Business Strategies

17.10. Oracle

17.10.1. Company Details

17.10.2. Company Overview

17.10.3. Product Offerings

17.10.4. Key Developments

17.10.5. Financial Analysis

17.10.6. SWOT Analysis

17.10.7. Business Strategies

17.11. PierianDx

17.11.1. Company Details

17.11.2. Company Overview

17.11.3. Product Offerings

17.11.4. Key Developments

17.11.5. Financial Analysis

17.11.6. SWOT Analysis

17.11.7. Business Strategies

17.12. SOPHiA GENETICS

17.12.1. Company Details

17.12.2. Company Overview

17.12.3. Product Offerings

17.12.4. Key Developments

17.12.5. Financial Analysis

17.12.6. SWOT Analysis

17.12.7. Business Strategies

17.13. Syapse, Inc.

17.13.1. Company Details

17.13.2. Company Overview

17.13.3. Product Offerings

17.13.4. Key Developments

17.13.5. Financial Analysis

17.13.6. SWOT Analysis

17.13.7. Business Strategies

17.14. Translational Software

17.14.1. Company Details

17.14.2. Company Overview

17.14.3. Product Offerings

17.14.4. Key Developments

17.14.5. Financial Analysis

17.14.6. SWOT Analysis

17.14.7. Business Strategies

17.15. TupeloLife

17.15.1. Company Details

17.15.2. Company Overview

17.15.3. Product Offerings

17.15.4. Key Developments

17.15.5. Financial Analysis

17.15.6. SWOT Analysis

17.15.7. Business Strategies

17.16. Other Market Participants

18. Key Findings

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com